China's manufacturing activity contracted sharply in December for the third month in a row, according to Purchasing Managers' Index (PMI)
The coutry’s PMI came in at 47 points, down from November's 48 and well below the 50-point mark separating growth from contraction, despite China loosening COVID restrictions at the beginning of the month.
For over two years, China had imposed a zero-COVID strategy with strict quarantines, lockdowns, and mass testing that led to unannounced plant closures, disrupted supply chains, and forced permanent company closures.
China abruptly loosened pandemic restrictions on December 7, but the country is still struggling to recover due to a surge in COVID cases.
NBS senior statistician Zhao Qinghe noted that the pandemic has had a significant impact on business production and demand, staff presence, logistics, and distribution.
The index has not been in positive territory since September, and December's figure was lower than the 47.8 reading predicted by Bloomberg analysts.
For its part, the non-manufacturing PMI -- which includes the services and construction sectors -- also contracted further this month, to 41.6 points from 46.7 in November.


Johns Hopkins University Lays Off 110 Employees as Federal Research Funding Declines
Bayer Wins Major U.S. Supreme Court Roundup Lawsuit, Shares Surge
Oil Prices Rebound as Strait of Hormuz Tensions Return After Ship Attack Near Oman
Bain Capital Nears Deal for Majority Stake in Volkswagen Marine Engine Unit Everllence
Why the future of marijuana legalization remains hazy despite high public support
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal
BOJ Hawk Signals Faster Interest Rate Hikes Amid Inflation Risks
Trump Threatens 100% Tariffs on Countries Imposing Digital Services Taxes on U.S. Tech Firms
RFK Jr. Orders Extended Hantavirus Quarantine for Cruise Passenger
Asian Currencies Trade Mixed as Yen Hovers Near 40-Year Low, Dollar Holds Firm on Fed Outlook
Bank Regulation Rollbacks in the U.S. and UK Could Increase Financial Risks, Study Warns
Morgan Stanley Sees Chinese Auto Market Recovery Gaining Momentum in Late Summer
Alibaba Shares Fall After Anthropic Alleges Massive AI Model Distillation Campaign
AstraZeneca Q1 2026 Earnings Surge on Strong Oncology and Rare Disease Drug Sales
CDC Confirms U.S. Ebola Case Linked to Congo Outbreak as Travel Restrictions Tighten
Oil Prices Drop as Strait of Hormuz Shipping Recovers
SK Hynix Targets $29.4 Billion Nasdaq Listing to Expand AI Chip Business 



